This is exactly right. I don’t know how and if someone can get to Dr NP to help alleviate some of these missteps. As other have mentioned.. someone, or a team more likely, that has brought big drugs to market, development and public relations. That would help our SP wildly. We are more vulnerable to swings and irrational trading given our position on OTC and the strange attraction of our stock to brutal short sellers, but we definitely could have a little more stability at minimum. And better stability might bring more cautious money to the table. We’re on the way, I only wish the flight plan was a little more straightforward. Some of these things we have been targeted for are just totally unnecessary. And the company deserves better given all the hard work put in and the promise of the drug.
News 
Market Data 
Discover 
AI
